CRISPR Therapeutics AG (CRSP) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026)
CRISPR Therapeutics AG (CRSP) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
CRISPR Therapeutics AG |
5.21 Bn |
2.76 Bn |
- |
-11.57% |
| Date | Value |
|---|
| Mar 31, 2026 |
-11.57% |
| Dec 31, 2025 |
-10.87% |
| Sep 30, 2025 |
-10.07% |
| Jun 30, 2025 |
-8.89% |
| Mar 31, 2025 |
-6.33% |
| Dec 31, 2024 |
-0.85% |
| Sep 30, 2024 |
9.38% |
| Jun 30, 2024 |
23.78% |
| Mar 31, 2024 |
41.56% |
| Dec 31, 2023 |
53.32% |
| Sep 30, 2023 |
60.27% |
| Jun 30, 2023 |
66.57% |
| Mar 31, 2023 |
72.19% |
| Dec 31, 2022 |
73.50% |
| Sep 30, 2022 |
99.01% |
| Jun 30, 2022 |
101.62% |
| Mar 31, 2022 |
102.82% |
| Dec 31, 2021 |
95.19% |
| Sep 30, 2021 |
80.19% |
| Jun 30, 2021 |
60.05% |
